Cabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
Follow CBT
Alert me
Cabot Corporation (CBT) P/S ratio
As of 5 November 2026, Cabot Corporation (CBT) trades at a P/S ratio of 1.0×. Over the past ten years it has ranged from 0.4× (March 2020) to 1.6× (November 2024); the current reading is higher than 47% of that period. That is below the Specialty Chemicals industry median of 1.6× and below the Basic Materials sector median of 1.6×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.1× | (28.67%) |
| FY2024 | 1.5× | 58.80% |
| FY2023 | 1.0× | 16.23% |
| FY2022 | 0.8× | 0.22% |
| FY2021 | 0.8× | 6.86% |
| FY2020 | 0.8× | (2.15%) |
| FY2019 | 0.8× | (33.24%) |
| FY2018 | 1.2× | (9.25%) |
| FY2017 | 1.3× | (2.99%) |
| FY2016 | 1.4× | 94.63% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 1.1× | (17.97%) |
| Jun 2026 | 1.3× | 17.73% |
| Mar 2026 | 1.1× | 13.11% |
| Dec 2025 | 1.0× | (11.96%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| FUL H. B. Fuller Company compare | 0.8× |
| CLMT Calumet, Inc. compare | 0.8× |
| CBT Cabot Corporation | 1.0× |
| AVNT Avient Corporation compare | 1.2× |
| ASH Ashland Inc. compare | 1.9× |
| HWKN Hawkins, Inc. compare | 2.8× |
| SXT Sensient Technologies Corporation compare | 2.9× |
| WDFC WD-40 Company compare | 4.4× |
| PRM Perimeter Solutions, SA compare | 5.6× |
| Specialty Chemicals industry median | 1.6× |
| Basic Materials sector median | 1.6× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on CBT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement